Serum Institute Files 100 Crores Case After Man Says Vaccine Left Him Ill

0
233

The Serum Institute of India has responded to “malicious and misconceived” allegations by preparing a ₹ 100 crore defamation suit against a Covishield coronavirus vaccine trial participant who claimed to suffer a “virtual neurological breakdown” after being administered a dose.

the Serum Institute said that while it sympathised with the volunteer’s medical condition there was “absolutely no correlation with the vaccine trial and the medical condition of the volunteer”.

“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer. The volunteer is falsely laying the blame for his medial problems on the COVID vaccine trial,” the statement said

“The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent. In spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company,” the statement added.

READ  Govt removes price cap on innovative drugs for first 5 years